News

Denis Chem Lab Limited, a manufacturer of parenteral products, submitted a certificate to the BSE Limited on October 7, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as issued by MUFG Intime India Private Limited, its registrar and share transfer agent.

Denis Chem Lab Limited, a manufacturer of parenteral products, informed the BSE Limited that its trading window will be closed from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ended September 30, 2026, in accordance with SEBI’s insider trading regulations.

Denis Chem Lab Limited announced that shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026, through a virtual Annual General Meeting on September 25, 2026. Dr. Patel, who holds DIN 00087114, was re-appointed in place of his expiring term on July 31, 2026, and is not debarred from holding the office, according to a filing with the BSE Limited.

Denis Chem Lab Limited announced that shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026, through a virtual Annual General Meeting on September 25, 2026. Dr. Patel, who holds DIN: 00087114, was re-appointed in place of his expiring term on July 31, 2026, and is not debarred from holding the office, according to a filing with the BSE Limited.

Denis Chem Lab will hold a meeting of the Board of Directors of the Company on 13 August 2026.